Showing results (131-140 of 168) with videos related to

Sort By:
Pageof 17
The American Journal of Cardiology|November 11, 1991
Reduced left ventricular cavitary activity ("black hole sign") in thallium-201 SPECT perfusion images of anteroapical transmural myocardial infarctionA C Civelek, I Shafique, J A Brinker, et al.
The American Journal of Cardiology|December 25, 1992
Detection of left anterior descending coronary artery disease in patients with left bundle branch blockA C Civelek, I Gozukara, K Durski, et al.
Annals of Internal Medicine|November 1, 1986
Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosisE L Alexander, G S Firestein, J L Weiss, et al.
Journal of the American College of Cardiology|June 1, 1993
Net costs from three perspectives of using low versus high osmolality contrast medium in diagnostic angiocardiographyN R Powe, A J Davidoff, R D Moore, et al.
Journal of Addiction Medicine|January 7, 2017
Coronary Plaque Progression and Regression in Asymptomatic African American Chronic Cocaine Users With Obstructive Coronary Stenoses: A Preliminary StudyVeit Sandfort, David A Bluemke, Jose Vargas, et al.
Circulation|February 1, 1994
Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosisC M Otto, M C Mickel, J W Kennedy, et al.
Journal of the American College of Cardiology|August 1, 1985
Regional wall motion improvement after coronary thrombolysis with recombinant tissue plasminogen activator: importance of coronary angioplastyE J Topol, J L Weiss, J A Brinker, et al.
Circulation|December 1, 1984
Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trialD Collen, E J Topol, A J Tiefenbrunn, et al.
Circulation|November 1, 1995
In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty. Results from a randomized clinical trial. Stent Restenosis Study InvestigatorsD J Cohen, H M Krumholz, C A Sukin, et al.
The New England Journal of Medicine|December 24, 1987
A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplastyA D Guerci, G Gerstenblith, J A Brinker, et al.
Pageof 17